imiquimod has been researched along with Depression in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di, T; Guo, J; Guo, X; Li, P; Liu, Y; Meng, Y; Qi, C; Wang, Y; Zhang, L; Zhao, J | 1 |
| Ahmad, SF; Al-Harbi, NO; Attia, SM; El-Sherbeeny, AM; Fardan, AS; Ibrahim, KE; Nadeem, A | 1 |
| Schmutz, JL; Trechot, P | 1 |
| Hiraide, S; Kubo, Y; Matsumoto, M; Togashi, H; Yanagawa, Y | 1 |
| Dalrymple, J; Hanger, C; Hepburn, D | 1 |
5 other study(ies) available for imiquimod and Depression
| Article | Year |
|---|---|
Depressive-like behaviors in mice with Imiquimod-induced psoriasis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Cytokines; Depression; Disease Models, Animal; Epinephrine; Exploratory Behavior; Fluoxetine; Food Preferences; gamma-Aminobutyric Acid; Imiquimod; Male; Mice, Inbred BALB C; Neurotransmitter Agents; Norepinephrine; Open Field Test; Psoriasis; Serotonin; Skin | 2020 |
IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression.
Topics: Aminoquinolines; Animals; Brain; Depression; Depressive Disorder, Major; Disease Models, Animal; Humans; Imiquimod; Inflammation; Interleukin-17; MAP Kinase Signaling System; Mice; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Psoriasis | 2017 |
[Psychiatric disorders associated with use of imiquimod].
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dementia; Depression; Female; Humans; Imiquimod; Immunologic Factors; Male; Mental Disorders; Middle Aged; Psychomotor Agitation; Skin Neoplasms; Sleep Initiation and Maintenance Disorders | 2014 |
Enhanced depressive-like behaviors after Toll-like receptor 7 stimulation in mice.
Topics: Aminoquinolines; Animals; Behavior, Animal; Cytokines; Depression; Hippocampus; Imiquimod; Interferon Inducers; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; RNA, Messenger; Toll-Like Receptor 7 | 2013 |
Systemic side effects from topical imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Blood Sedimentation; Carcinoma, Basal Cell; Depression; Facial Neoplasms; Fatigue; Feeding and Eating Disorders; Humans; Hypotension, Orthostatic; Imiquimod; Male; Treatment Outcome; Weight Loss | 2005 |